Using next generation sequencing (NGS) in a bone marrow specimen from a patient with AML and synchronous plasma cell myeloma, we have identified a CD36/Y325* mutation, which would encode a truncated protein lacking the signaling intracytoplasmic carboxyl-terminus end. The gene discussed is CD36; the disease is acute myeloid leukemia.